Methyltransferase-like Proteins in Cancer Biology and Potential Therapeutic Targeting

Overview

Journal J Hematol Oncol

Publisher Biomed Central

Specialties Hematology
Oncology

Date 2023 Aug 2

PMID 37533128

Authors

Ya-Nan Qi

Zhu Liu

Lian-Lian Hong

Pei Li

Zhi-Qiang Ling

Affiliations

Soon will be listed here.

Abstract

RNA modification has recently become a significant process of gene regulation, and the methyltransferase-like (METTL) family of proteins plays a critical role in RNA modification, methylating various types of RNAs, including mRNA, tRNA, microRNA, rRNA, and mitochondrial RNAs. METTL proteins consist of a unique seven-beta-strand domain, which binds to the methyl donor SAM to catalyze methyl transfer. The most typical family member METTL3/METTL14 forms a methyltransferase complex involved in N6-methyladenosine (m6A) modification of RNA, regulating tumor proliferation, metastasis and invasion, immunotherapy resistance, and metabolic reprogramming of tumor cells. METTL1, METTL4, METTL5, and METTL16 have also been recently identified to have some regulatory ability in tumorigenesis, and the rest of the METTL family members rely on their methyltransferase activity for methylation of different nucleotides, proteins, and small molecules, which regulate translation and affect processes such as cell differentiation and development. Herein, we summarize the literature on METTLs in the last three years to elucidate their roles in human cancers and provide a theoretical basis for their future use as potential therapeutic targets.

Citing Articles

RNA Modification in Metabolism.

Liu Y, Sun Z, Gui D, Zhao Y, Xu Y MedComm (2020). 2025; 6(3):e70135.

PMID: 40066222 PMC: 11892166. DOI: 10.1002/mco2.70135.

The Role of MATN3 in Cancer Prognosis and Immune Infiltration Across Multiple Tumor Types.

Qin C, Qin H, Xie H, Li Y, Bi A, Liao X J Cancer. 2025; 16(5):1519-1537.

PMID: 39991588 PMC: 11843250. DOI: 10.7150/jca.103523.

The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes.

Shi T, Zhang H, Chen Y Cell Biosci. 2025; 15(1):27.

PMID: 39987091 PMC: 11846233. DOI: 10.1186/s13578-025-01368-z.

Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications.

Li P, Fang X, Huang D Eur J Med Res. 2025; 30(1):98.

PMID: 39940056 PMC: 11823136. DOI: 10.1186/s40001-025-02353-5.

Golgi scaffold protein PAQR11 in pan-cancer landscape: A comprehensive bioinformatics exploration of expression patterns, prognostic significance, and potential immunological function.

Liu Z, Ling Z Heliyon. 2025; 11(2):e41724.

PMID: 39906812 PMC: 11791267. DOI: 10.1016/j.heliyon.2025.e41724.

References

Zhu S, Wu Y, Zhang X, Peng S, Xiao H, Chen S . Targeting N-methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation. Mol Ther. 2022; 31(6):1596-1614. PMC: 10278047. DOI: 10.1016/j.ymthe.2022.08.004. View

Liu P, Fan B, Othmane B, Hu J, Li H, Cui Y . mA-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism. Theranostics. 2022; 12(14):6291-6307. PMC: 9475447. DOI: 10.7150/thno.71456. View

Liu Q, Li Z, He L, Li K, Hu C, Chen J . Molecular Characterization and Clinical Relevance of N-Methyladenosine Regulators in Metastatic Prostate Cancer. Front Oncol. 2022; 12:914692. PMC: 9257042. DOI: 10.3389/fonc.2022.914692. View

Ruszkowska A, Ruszkowski M, Dauter Z, Brown J . Structural insights into the RNA methyltransferase domain of METTL16. Sci Rep. 2018; 8(1):5311. PMC: 5871880. DOI: 10.1038/s41598-018-23608-8. View

Yu R, Wei Y, He C, Zhou P, Yang H, Deng C . Integrative Analyses of m6A Regulators Identify that METTL3 is Associated with HPV Status and Immunosuppressive Microenvironment in HPV-related Cancers. Int J Biol Sci. 2022; 18(9):3874-3887. PMC: 9254478. DOI: 10.7150/ijbs.70674. View

Jakobsson M . Structure, Activity and Function of the Dual Protein Lysine and Protein N-Terminal Methyltransferase METTL13. Life (Basel). 2021; 11(11). PMC: 8624817. DOI: 10.3390/life11111121. View

Zeng C, Huang W, Li Y, Weng H . Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020; 13(1):117. PMC: 7457244. DOI: 10.1186/s13045-020-00951-w. View

Han H, Yang C, Ma J, Zhang S, Zheng S, Ling R . N-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis. Nat Commun. 2022; 13(1):1478. PMC: 8933395. DOI: 10.1038/s41467-022-29125-7. View

Dong L, Chen C, Zhang Y, Guo P, Wang Z, Li J . The loss of RNA N-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8 T cell dysfunction and tumor growth. Cancer Cell. 2021; 39(7):945-957.e10. DOI: 10.1016/j.ccell.2021.04.016. View

10.

Ruan P, Wang S, Yang C, Huang X, Sun P, Tan A . mA mRNA methylation regulates the ERK/NF-κB/AKT signaling pathway through the PAPPA/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer. Cell Biol Toxicol. 2022; 39(4):1611-1626. DOI: 10.1007/s10565-022-09751-z. View

11.

Gao Z, Long Y, Wu Y, Pu Y, Xue F . LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer. Carcinogenesis. 2022; 43(5):419-429. DOI: 10.1093/carcin/bgac018. View

12.

Goh Y, Koh C, Sim D, Roca X, Goh W . METTL4 catalyzes m6Am methylation in U2 snRNA to regulate pre-mRNA splicing. Nucleic Acids Res. 2020; 48(16):9250-9261. PMC: 7498333. DOI: 10.1093/nar/gkaa684. View

13.

Liu Y, Liang G, Xu H, Dong W, Dong Z, Qiu Z . Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metab. 2021; 33(6):1221-1233.e11. DOI: 10.1016/j.cmet.2021.04.001. View

14.

Li Q, Li X, Tang H, Jiang B, Dou Y, Gorospe M . NSUN2-Mediated m5C Methylation and METTL3/METTL14-Mediated m6A Methylation Cooperatively Enhance p21 Translation. J Cell Biochem. 2017; 118(9):2587-2598. PMC: 5509477. DOI: 10.1002/jcb.25957. View

15.

Chen Y, Pan C, Wang X, Xu D, Ma Y, Hu J . Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. Theranostics. 2021; 11(16):7640-7657. PMC: 8315076. DOI: 10.7150/thno.61178. View

16.

Rong B, Zhang Q, Wan J, Xing S, Dai R, Li Y . Ribosome 18S mA Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth. Cell Rep. 2020; 33(12):108544. DOI: 10.1016/j.celrep.2020.108544. View

17.

Huang H, Weng H, Chen J . mA Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. Cancer Cell. 2020; 37(3):270-288. PMC: 7141420. DOI: 10.1016/j.ccell.2020.02.004. View

18.

Malecki J, Ho A, Moen A, Dahl H, Falnes P . Human METTL20 is a mitochondrial lysine methyltransferase that targets the β subunit of electron transfer flavoprotein (ETFβ) and modulates its activity. J Biol Chem. 2014; 290(1):423-34. PMC: 4281744. DOI: 10.1074/jbc.M114.614115. View

19.

Wang P, Doxtader K, Nam Y . Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. Mol Cell. 2016; 63(2):306-317. PMC: 4958592. DOI: 10.1016/j.molcel.2016.05.041. View

20.

Chen H, Pan Y, Zhou Q, Liang C, Wong C, Zhou Y . METTL3 Inhibits Antitumor Immunity by Targeting mA-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer. Gastroenterology. 2022; 163(4):891-907. DOI: 10.1053/j.gastro.2022.06.024. View